Treating the neurodegenerative disease in its earlier stages is key to slowing cognitive decline. A new study offers hope for ...

Ambroxol is commonly used as an expectorant in cough syrup, helping thin out mucus so people with respiratory illnesses can ...

UCLA Health researchers have identified four distinct pathways that lead to Alzheimer's disease by analyzing electronic ...

The human brain comprises billions of neurons, synapses, and cell types, making it one of the universe's most intricate and ...

Researchers at the Francis Crick Institute and UCL have shown that genetic messages are misplaced in nerve cells in a model ...

An analysis of 1.7 million patients shows semaglutide may significantly reduce Alzheimer and vascular dementia risk compared ...

The UK’s National Institute for Health and Care Excellence (Nice) has declined to recommend two new Alzheimer’s drugs for ...

Scientists are to examine whether drugs that are already in use could be repurposed to treat the symptoms of both Alzheimer’s disease and Parkinson’s in a new collaboration which aims to discover ...

Home Health the explainer Why people can't access dementia 'wonder' drugs New immunotherapy drugs offer some hope in the fight against Alzheimer's disease but they're too pricey for the NHS ...

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Alzheimer’s Drug Market size & share revenue was valued at ...

To no great surprise, the U.K.’s health technology assessment body has found that the benefits of the first two approved Alzheimer’s disease drugs are too small to justify the costs. Neither Kisunla ...